Lilly's Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 3, 2021 at 11:32 AM.

  1. #1 cafead, Jun 3, 2021 at 11:32 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,046
    Likes Received:
    3
    via Eli Lilly And Co (NYSE: LLY) has reported posthoc analyses data from the Phase 3 RA-BEAM study that showed Olumiant 4mg (baricitinib) lowered pain and duration of morning joint stiffness in moderate to severe rheumatoid arthritis (RA) patients.

    article source
     
    Quote

Reply to Thread